“The House Health Committee is preparing for the next several weeks of session and invites you to offer feedback on the following bills:
HB916 – Requiring universal child lead testing. (NB: this bill is expected to be amended in committee to resemble HB2041)
HB2341 – Contracting for a standardized risk assessment platform for health care facilities.
HB2162 – Allowing state licensure for pharmaceutical manufacturers prior to FDA approval of a drug.
HB1365 – Creating the Medication-Induced Movement Disorder Education Program
SB 804 – Phasing out IV bags with DEHP
SB614 – Providing funding for primary care preceptorships out of the Rural Health Transformation Fund.
HB916 has been designated to run on April 15th, along with HB836 and HB2254 (previously sent out for feedback.)
Other legislation may run on April 28th or May 6th.”